Tieman Flashcards
(69 cards)
herpes simplex virus (HS1/HS2) shape
large double stranded DNA
enveloped
HSV1 location
oral mucosa
HSV2 location
genital mucosa
HSV locations in immunocompromised patients
eye
skin
visceral organs
CNS
HSV1 establishes in what ganglia
trigeminal (sensory) ganglia
diagnosis of HSV1 how
PCR test and swab
HSV1 presentation
cold sores or ulcers in mouth
HSV2 presentation
bumps, blisters, ulcers around genitals or anus
HSV2 esablishes in what ganglia
sacral ganglia
diagnosis of HSV2 how
PCR and swab
HSV encephalitis usually caused by which HSV
HSV1
most adults are seropositive for what
HSV1
diagnosis of HSV encephalitis how
lumbar puncture and PCR testing
symptoms of HSV encephalitis
fever
confusion
personality changes
headache
seizure
focal neurological effects
acyclovir MOA
competitive inhibitor of viral DNA polymerase
incorporated into viral DNA causing chain termination
bioavailability of acyclovir
poor bioavailability
not affected by food
how is acyclovir eliminated
renally, need to dose adjust
adverse effects of acyclovir
N/V/D
rash
headache (oral)
nephrotoxicity
neurotoxicity
thrombophlebitis
renal consideration with acyclovir
need to renal dose adjust
high risk nephrotox
give IV fluids with
genital HSV treatment primary infection
acyclovir 400 mg TID x 7-10 days
acyclovir 200 mg 5x/day x 7-10 days
valacyclovir 1 g BID x 7-10 days
famciclovir 250 mg TID x 7-10 days
genital HSV treatment recurrent infection
acyclovir 800 mg BID x 5 days
acyclovir 800 mg TID x 2 days
valacyclovir 500 mg BID x 3 days
valacyclovir 500 mg 1 g daily x 5 days
genital HSV treatment for suppression in immunocompromised
valacyclovir 500-1000 mg daily (1 g if >10 epsidoes/year)
acyclovir 400 mg BID
famciclovir 250 mg BID
once daily preferred
genital HSV treatment for suppression in HIV patients
valacyclovir 500 BID
oral HSV treatment
acyclovir 400 mg TID x 5-10 days
valacyclovir 2 g BID x 1 day
famciclovir 1.5 g single dose